Skip to content

Physiological Finding in Management of COVID 19 Patients

The Combined Usage of Clinical Physiological Finding in Management of COVID 19 Patients

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07504341
Acronym
COVID-19
Enrollment
15000
Registered
2026-03-31
Start date
2026-04-01
Completion date
2027-03-31
Last updated
2026-03-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19 (Coronavirus Disease 2019)

Keywords

COVID-19, shock index, mordified shock index, Age shock index, respiratory adjusted shock index

Brief summary

This study utilizes physiological indicators of COVID-19 patients as tools for assessing, tracking, worsening, and improving the clinical symptoms of COVID-19 patients. This study employs simple and easy-to-use assessment methods, which can be further aided by artificial intelligence technology to facilitate early response and medication.

Detailed description

This study utilizes physiological indicators of COVID-19 patients, such as blood pressure, heart rate, respiratory rate, and level of consciousness, to develop Shock Index (SI), Mordified Shock Index (MSI), Age Shock Index (Age SI), Age Mordified Shock Index (Age MSI), and Respiratory Adjusted Shock Index (RASI), as well as other physiological indicators, as tools for assessing, tracking, worsening, and improving the clinical symptoms of COVID-19 patients. For patients with mild to severe illness, and in response to the shortage of manpower during a large influx of emergency patients, this study employs simple and easy-to-use assessment methods, which can be further aided by artificial intelligence technology to facilitate early response and medication.

Interventions

OTHERphysiological parameters

systolic blood pressure, diastolic blood pressure , heart rate, respiratory rate , GCS

Sponsors

St. Martin De Porress Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Reviewing the patient's medical history, the primary focus was on hospital records and existing physiological parameters such as blood pressure, heart rate, respiratory rate, and level of consciousness. The patient received treatment at the hospital between May 2022 and March 2027

Exclusion criteria

* Excluding patients with incomplete clinical data or missing information in their medical records.

Design outcomes

Primary

MeasureTime frameDescription
Shock index(SI) in the management of COVID -192022 May to 2027 MarchSI= heart rate / systolic blood pressre
Mordified shock index(MSI) in the management of COVID -192022 May to 2027 MarchMSI=heart rate / mean arterial pressure
Age shock index(Age SI) in the management of COVID -192022 May to 2027 MarchAge shock index =Age x (heart rate / systolic blood pression)
Respiratory adjusted shock index (RASI) in the management of COVID-192022 may to 2027 MarchRespiratory adjusted shock index =(heart rate/systolic blood pression) x (repiratory rate/10)

Countries

Taiwan

Contacts

CONTACTChia-Hsi Chen, Physician
urologist3509@gmail.com886-5-2756000
CONTACTChia-Hsi Chen
urologist3509@gmail.com886-5-2756000
PRINCIPAL_INVESTIGATORChia-Hsi Chen, Physician

St. Martin De Porress Hospital

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 1, 2026